November 1st, 2023, Bhavika Bansal
In recent years, an unprecedented surge in the development of artificial intelligence (AI) and its ability to revolutionize daily life has been at the center of public conversation. AI continues to transform the way we interact with technology and perceive the future. But do consumers think AI will make things better or worse? And what do they think about the impact of AI on the diagnoses of medical conditions and diseases?
According to a recent YouGov Surveys: Serviced poll across 18 international markets, more than two out of five consumers believe that AI will make the experience of diagnosing medical conditions (43%) better in the next five years. This application of AI tops the list among all the options we explored in the survey, with its use in building a travel itinerary (42%) following closely behind. While slightly more than a third of global respondents say the same about booking or rebooking air travel (36%), generating or summarizing news content (35%), and providing customer service (34%), only a quarter feel the same way when it comes to managing personal finances (25%).
A closer look at those consumers’ opinions on the impact AI will have on medical diagnoses over the next five years, by region, reveals some interesting differences.
Substantially more than half of respondents in Mexico, Hong Kong, Spain and the UAE (58%, 55%, 55% and 54% respectively), believe that AI will enhance the diagnoses of medical diseases and conditions over the next five years.
Conversely, markets like the United States, Canada, Australia and Great Britain show more skepticism. In Great Britain, only 10% of respondents believe AI will make things better, while nearly a quarter (23%) expect it to have a negative impact.
More than three-tenths of Americans say they don’t know if AI will make things better, worse or have no impact in diagnosing medical conditions (33%), while another 26% say it will make things worse. Just slightly more than a quarter of Americans see AI having a positive impact in this activity (27%).
Though 28% of Danes and 25% of Swedes say they are not sure about AI's impact on diagnosing medical conditions, two-fifths of respondents (Sweden, 40%; Denmark, 38%) are likely to say AI will make things better in the next five years.
Explore our living data – for free
Try a subscription-free data snapshot of your brand performance, sector trends or audience profile, with a one-time deep dive into YouGov's flagship consumer intelligence and brand tracking products. Get your tailor-made snapshot here.
Discover more health and pharma content here
Want to run your own research? Run a survey now
Make smarter business decisions with better intelligence. Understand exactly what your audience is thinking by leveraging our panel of 20 million+ members. Speak with us today.
Methodology: YouGov Surveys: Serviced provide quick survey results from nationally representative or targeted audiences in multiple markets. The data is based on surveys of adults aged 18+ years in 18 markets with sample sizes varying between 437 and 2,045 for each market. All surveys were conducted online in June 2023. Data from each market uses a nationally representative sample apart from Mexico and India, which use urban representative samples, and Indonesia and Hong Kong, which use online representative samples. Learn more about YouGov Surveys: Serviced.